Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

MDXG

Mimedx Group Inc

Apr 16 • 10:51AM ET

6.26

Dollar change -0.09
Percentage change -1.34	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWN SCHA VTWO VHT DWAS LABU IWC

Scroll to Statements

Index	RUT	P/E	18.19	EPS (ttm)	0.34	Insider Own	23.12%	Shs Outstand	146.23M	Perf Week	-10.75%
Market Cap	920.70M	Forward P/E	14.57	EPS next Y	0.43	Insider Trans	-0.23%	Shs Float	112.98M	Perf Month	-20.49%
Income	51.47M	PEG	1.21	EPS next Q	0.04	Inst Own	41.67%	Short Float	4.58%	Perf Quarter	-22.46%
Sales	321.48M	P/S	2.86	EPS this Y	-13.51%	Inst Trans	3.14%	Short Ratio	6.66	Perf Half Y	-1.18%
Book/sh	0.98	P/B	6.42	EPS next Y	34.37%	ROA	27.30%	Short Interest	5.18M	Perf Year	89.27%
Cash/sh	0.56	P/C	11.23	EPS next 5Y	15.00%	ROE	51.59%	52W Range	3.31 - 9.27	Perf YTD	-28.56%
Dividend Est.	-	P/FCF	37.14	EPS past 5Y	-	ROI	26.85%	52W High	-32.42%	Beta	1.42
Dividend TTM	-	Quick Ratio	3.11	Sales past 5Y	-1.19%	Gross Margin	82.77%	52W Low	89.27%	ATR (14)	0.27
Dividend Ex-Date	-	Current Ratio	3.57	EPS Y/Y TTM	231.80%	Oper. Margin	9.08%	RSI (14)	24.35	Volatility	3.73% 3.80%
Employees	895	Debt/Eq	0.35	Sales Y/Y TTM	20.03%	Profit Margin	16.01%	Recom	1.00	Target Price	12.50
Option/Short	Yes / Yes	LT Debt/Eq	0.34	EPS Q/Q	1984.41%	Payout	0.00%	Rel Volume	0.38	Prev Close	6.35
Sales Surprise	2.01%	EPS Surprise	344.44%	Sales Q/Q	16.75%	Earnings	Feb 28 AMC	Avg Volume	776.92K	Price	6.26
SMA20	-14.37%	SMA50	-19.28%	SMA200	-16.98%	Trades		Volume	73,234	Change	-1.34%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-07-24	Initiated	Lake Street	Buy	$12
Oct-27-23	Initiated	Craig Hallum	Buy	$12
Oct-13-22	Initiated	Mizuho	Buy	$7
Jul-26-21	Initiated	Northland Capital	Outperform	$23
Mar-19-21	Initiated	H.C. Wainwright	Buy	$20

Today 08:00AM	MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30 (GlobeNewswire)
Apr-01-24 04:37PM	Spectral AI, Inc. (NASDAQ:MDAI) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-27-24 08:00AM	MIMEDX Provides Update on AXIOFILL Request for Designation ( RFD ) from FDA (GlobeNewswire)
Mar-20-24 07:00AM	MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing (GlobeNewswire)
Mar-13-24 08:00AM	MIMEDX Introduces E-Commerce and Account Management Platform (GlobeNewswire)
08:00AM	Loading…
Mar-04-24 08:00AM	MIMEDX Announces Appointment of Two New Independent Directors (GlobeNewswire)
Feb-29-24 10:49AM	MiMedx Group, Inc. (NASDAQ:MDXG) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-28-24 04:55PM	MiMedx Group Inc (MDXG) Reports Strong Year-Over-Year Sales Growth and Net Income Surge in Q4 ... (GuruFocus.com)
04:41PM	MiMedx: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results (GlobeNewswire)
Feb-21-24 11:51PM	MiMedx Group Inc Insider Sells Shares (GuruFocus.com)
Feb-20-24 08:00AM	MIMEDX to Present at TD Cowen 44th Annual Health Care Conference (GlobeNewswire)
Feb-13-24 12:58PM	Get Rich Quick With These 3 Biotech Stocks to Buy Now (InvestorPlace)
Feb-12-24 08:00AM	MIMEDX to Host Fourth Quarter and Full Year 2023 Operating and Financial Results Conference Call on February 28 (GlobeNewswire)
Jan-22-24 08:00AM	MIMEDX Announces Improved Capital Structure with New Senior Secured Credit Facilities and Debt Refinancing (GlobeNewswire)
10:25AM	Loading…
Jan-17-24 10:25AM	MiMedx Group Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm (GlobeNewswire)
Dec-29-23 05:12PM	MiMedx says US FDA's warning letter for Axiofill not related to safety (Reuters)
05:00PM	MIMEDX Provides AXIOFILL Update & Reiterates 2023 Full Year Net Sales and Fourth Quarter Adjusted EBITDA Margin Outlook (GlobeNewswire)
Dec-28-23 08:00AM	MIMEDX Announces Conversion of Outstanding Series B Convertible Preferred Stock to Common Stock (GlobeNewswire)
Nov-13-23 08:00AM	MIMEDX to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-02-23 08:00AM	MIMEDX to Highlight Published Data at SAWC Fall (GlobeNewswire)
Oct-31-23 09:09AM	MiMedx Group, Inc. (NASDAQ:MDXG) Q3 2023 Earnings Call Transcript (Insider Monkey)
07:28AM	Q3 2023 MiMedx Group Inc Earnings Call (Thomson Reuters StreetEvents)
06:50AM	MDXG: Xenografts and Synthetics Options for Expansion (Zacks)
Oct-30-23 06:03PM	MiMedx Group Inc (MDXG) Reports 20.7% Increase in Q3 2023 Net Sales (GuruFocus.com)
04:50PM	MiMedx: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	MIMEDX Announces Third Quarter 2023 Operating and Financial Results (GlobeNewswire)
Oct-27-23 10:01AM	Roblox upgraded, Bristol Myers downgraded: Wall Street's top analyst calls (The Fly)
Oct-16-23 08:00AM	MIMEDX to Host Third Quarter 2023 Operating and Financial Results Conference Call on October 30 (GlobeNewswire)
Sep-26-23 08:00AM	MIMEDX Announces Launch of EPIEFFECT (GlobeNewswire)
08:00AM	Loading…
Sep-05-23 08:00AM	MIMEDX to Present at Upcoming Investor Conferences (GlobeNewswire)
Aug-15-23 04:01PM	MediWound Announces Collaboration with MIMEDX on EscharEx® Phase III Study (GlobeNewswire)
Aug-08-23 02:05PM	Institutional owners may ignore MiMedx Group, Inc.'s (NASDAQ:MDXG) recent US$68m market cap decline as longer-term profits stay in the green (Simply Wall St.)
Aug-02-23 08:53AM	Q2 2023 MiMedx Group Inc Earnings Call (Thomson Reuters StreetEvents)
06:36AM	MDXG: Beat and a Raise (Zacks)
Aug-01-23 04:07PM	MiMedx: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	MIMEDX Announces Second Quarter 2023 Operating and Financial Results (GlobeNewswire)
Jul-26-23 01:30PM	Northland Capital Markets Institutional Investor Conference (ACCESSWIRE)
Jul-18-23 08:00AM	MIMEDX to Host Second Quarter 2023 Operating and Financial Results Conference Call on August 1 (GlobeNewswire)
Jul-11-23 08:30AM	MIMEDX Announces Favorable Ruling in Putative Securities Class Action Case (GlobeNewswire)
Jul-05-23 08:00AM	MIMEDX Appoints Doug Rice as Chief Financial Officer (GlobeNewswire)
Jul-03-23 03:59AM	5 hot insider trades & hedge fund hits: Buffett picks up more Occidental shares (Investing.com)
Jun-27-23 06:46AM	Daily Vickers Top Buyers & Sellers for 06/27/2023 (Argus Research)
Jun-22-23 11:13AM	MDXG: KOA Program Discontinued (Zacks Small Cap Research)
Jun-20-23 04:01PM	MIMEDX Announces Strategic Realignment: Increases Focus on Wound & Surgical Business, Expected to Significantly Improve Profitability (GlobeNewswire)
May-25-23 01:29PM	Breakeven On The Horizon For MiMedx Group, Inc. (NASDAQ:MDXG) (Simply Wall St.)
May-03-23 09:22AM	Q1 2023 MiMedx Group Inc Earnings Call (Thomson Reuters StreetEvents) +39.37%
07:21AM	MDXG: 1Q:22 Financial Results (Zacks Small Cap Research)
May-02-23 04:17PM	MiMedx: Q1 Earnings Snapshot (AP Finance)
04:01PM	MIMEDX Announces First Quarter 2023 Operating and Financial Results (GlobeNewswire)
Apr-18-23 08:00AM	MIMEDX to Host First Quarter 2023 Operating and Financial Results Conference Call on May 2 (GlobeNewswire)
Apr-13-23 08:29AM	Investors in MiMedx Group (NASDAQ:MDXG) have unfortunately lost 57% over the last five years (Simply Wall St.) +6.05%
Mar-23-23 04:01PM	MIMEDX Announces Chief Financial Officer Transition (GlobeNewswire)
Mar-16-23 08:00AM	MIMEDX Comments on Recent Data Brief Published by Office of Inspector General (GlobeNewswire)
Mar-03-23 11:17AM	MiMedx Group, Inc. (NASDAQ:MDXG) Q4 2022 Earnings Call Transcript (Insider Monkey) +13.04%
05:17AM	MiMedx Group Full Year 2022 Earnings: In Line With Expectations (Simply Wall St.)
Mar-01-23 11:22AM	Institutional investors own a significant stake of 38% in MiMedx Group, Inc. (NASDAQ:MDXG) (Simply Wall St.) -12.99%
10:13AM	Q4 2022 MiMedx Group Inc Earnings Call (Thomson Reuters StreetEvents)
04:21AM	MDXG: 2022 Financial Results (Zacks Small Cap Research)
Feb-28-23 04:01PM	MIMEDX Announces Fourth Quarter and Full Year 2022 Operating and Financial Results (GlobeNewswire)
Feb-15-23 08:00AM	MIMEDX to Host Fourth Quarter and Full Year 2022 Operating and Financial Results Conference Call on February 28 (GlobeNewswire)
Jan-31-23 05:38AM	MDXG: Navigating to New Heights: MiMedx Appoints CEO (Zacks Small Cap Research)
Jan-30-23 08:00AM	MIMEDX Appoints Joseph H. Capper as Chief Executive Officer and Director (GlobeNewswire)
Jan-09-23 08:02AM	MIMEDX Confirms Fourth Quarter and Full Year 2022 Net Sales Expectations, Comments on Evolving Medicare Reimbursement Landscape and Provides Corporate Updates (GlobeNewswire)
Jan-04-23 04:01PM	MIMEDX Announces Commercial Launch of EPIFIX® in Japan with Exclusive Distribution Agreement with GUNZE MEDICAL LIMITED (GlobeNewswire)
Jan-03-23 08:00AM	MIMEDX Appoints Ricci S. Whitlow as Chief Operating Officer (GlobeNewswire) +6.83%
Dec-08-22 08:00AM	MIMEDX Announces Wound & Surgical Product Pipeline Expansion via In-Licensing and Distribution Agreement with Turn Therapeutics (GlobeNewswire)
Nov-10-22 08:00AM	MIMEDX to Present at Upcoming Investor Conferences (GlobeNewswire) +10.69%
Nov-03-22 06:32AM	MDXG: KOA Trial Launch Around the Corner (Zacks Small Cap Research) +5.43%
Nov-02-22 04:15PM	MIMEDX Announces Third Quarter 2022 Operating and Financial Results (GlobeNewswire) -8.61%
08:03AM	The past five years for MiMedx Group (NASDAQ:MDXG) investors has not been profitable (Simply Wall St.)
Oct-19-22 08:00AM	MIMEDX to Host Third Quarter 2022 Operating and Financial Results Conference Call on November 2 (GlobeNewswire)
Oct-04-22 08:00AM	MIMEDX Appoints Matt Notarianni as Head of Investor Relations (GlobeNewswire)
Sep-23-22 11:18AM	MDXG: New Product Launches (Zacks Small Cap Research)
Sep-22-22 10:10AM	Institutions along with individual investors who hold considerable shares inMiMedx Group, Inc. (NASDAQ:MDXG) come under pressure; lose 14% of holdings value (Simply Wall St.)
Sep-20-22 08:00AM	MIMEDX Announces Launch of AXIOFILL (GlobeNewswire) -5.25%
Sep-19-22 07:00AM	MIMEDX Announces Launch of AMNIOEFFECT (GlobeNewswire)
Sep-12-22 04:30PM	MIMEDX EPIFIX® Receives Reimbursement Approval in Japan (GlobeNewswire)
12:59PM	MIMEDX, public regenerative medicine company, joins the RegenMed Hubs Innovation Accelerator in Winston-Salem (American City Business Journals)
05:13AM	MDXG: New Captain on the Bridge (Zacks Small Cap Research)
Sep-06-22 07:00AM	MIMEDX Announces Leadership Transition (GlobeNewswire)
Aug-26-22 09:00AM	Regenerative Engineering Society Establishes Award in Honor of MIMEDX Board Member, Dr. Cato T. Laurencin (GlobeNewswire)
Aug-04-22 04:07PM	MIMEDX to Present at the Canaccord Genuity 42nd Annual Growth Conference (GlobeNewswire)
05:30AM	MDXG: 2Q:22 Financial and Operational Results (Zacks Small Cap Research)
Aug-02-22 04:05PM	MIMEDX Announces Second Quarter 2022 Operating and Financial Results (GlobeNewswire)
Jul-27-22 08:00AM	MIMEDX Announces Formation of Regenerative Medicine Scientific Advisory Board Comprised of Renowned Industry and Academic Experts (GlobeNewswire)
Jul-24-22 10:38AM	Is MiMedx Group (NASDAQ:MDXG) Using Too Much Debt? (Simply Wall St.)
Jul-20-22 08:00AM	MIMEDX to Host Second Quarter 2022 Operating and Financial Results Conference Call on August 3 (GlobeNewswire)
Jul-18-22 09:35AM	MIMEDX Welcomes Kate Surdez as Chief Human Resources Officer (GlobeNewswire)
Jun-15-22 08:30AM	MIMEDX Engages Nordic Bioscience Clinical Development A/S to Propel Registrational Trials of Placental Biologic Injectable for Knee Osteoarthritis (GlobeNewswire) +9.20%
Jun-14-22 05:16PM	Prescience Point Capital Management Says MiMedx Shareholders Have Spoken: Voiced Their Desire For Change (PR Newswire)
Jun-07-22 04:05PM	MIMEDX Shareholders Vote to Approve All Proposals at the 2022 Annual Meeting (GlobeNewswire)
02:42PM	Prescience Point Capital Management Calls On MiMedx Group to Immediately Release Preliminary Voting Results of its Annual Meeting (PR Newswire)
Jun-03-22 08:00AM	MIMEDX Reminds Shareholders to Pre-Register for the Upcoming Virtual 2022 Annual Meeting of Shareholders (GlobeNewswire)
Jun-02-22 08:03AM	MIMEDX Addresses Presentation by Prescience Point (GlobeNewswire)
May-31-22 04:05PM	MIMEDX Board Chair Dr. M. Kathleen Behrens Writes Letter to Fellow Shareholders (GlobeNewswire)
02:05PM	Prescience Point Capital Management Releases Presentation Detailing Board And Management Failures at MiMedx Group (PR Newswire)
08:00AM	MIMEDX Receives $4.6 Million Award from the Department of Defense to Advance the Treatment of Combat Casualty Wounds and Burns (GlobeNewswire)
May-25-22 05:26PM	Leading Independent Proxy Advisory Firm ISS Recommends that MIMEDX Shareholders Vote FOR ALL of the Companys Proposals (GlobeNewswire)
May-20-22 09:00AM	Leading Independent Proxy Advisory Firm Glass Lewis Recommends that MIMEDX Shareholders Vote FOR ALL of the Companys Proposals (GlobeNewswire)

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hulse William Frank IV	General Counsel and CAO	Mar 13 '24	Sale	7.95	20,381	162,029	479,959	Mar 15 06:35 PM
Whitlow Ricci S	Chief Operating Officer	Feb 20 '24	Sale	8.01	15,271	122,351	401,050	Feb 21 04:40 PM
Whitlow Ricci S	Chief Operating Officer	Feb 16 '24	Sale	8.07	15,493	125,075	416,321	Feb 21 04:40 PM
Whitlow Ricci S	Chief Operating Officer	Feb 15 '24	Sale	8.06	15,198	122,496	431,814	Feb 16 04:22 PM
Whitlow Ricci S	Chief Operating Officer	Feb 14 '24	Sale	8.03	15,845	127,267	447,012	Feb 16 04:22 PM
DOUG RICE	Chief Financial Officer	Nov 21 '23	Buy	7.16	5,000	35,786	102,200	Nov 22 05:01 PM
Stein Robert Benjamin	President, Regenerative Med.	May 16 '23	Sale	5.95	10,365	61,627	317,803	May 17 06:26 PM
Stein Robert Benjamin	President, Regenerative Med.	May 15 '23	Sale	6.15	3,607	22,170	328,168	May 17 06:26 PM
Carlson Peter M	Chief Financial Officer	May 10 '23	Sale	5.93	5,976	35,414	656,435	May 12 06:50 PM
Hulse William Frank IV	General Counsel and CAO	May 10 '23	Sale	5.93	5,870	34,786	456,564	May 12 06:58 PM
Stein Robert Benjamin	President, Regenerative Med.	May 10 '23	Sale	5.93	5,869	34,780	331,775	May 12 06:56 PM
Phelan William Lawrence	Chief Accounting Officer	May 10 '23	Sale	5.93	1,595	9,452	184,219	May 12 06:53 PM
Stein Robert Benjamin	President, Regenerative Med.	May 04 '23	Sale	5.34	51,756	276,470	337,644	May 09 08:32 AM
Phelan William Lawrence	Chief Accounting Officer	May 02 '23	Sale	3.80	5,200	19,739	185,814	May 03 06:26 PM
Carlson Peter M	Chief Financial Officer	Apr 25 '23	Sale	3.74	6,094	22,816	662,411	Apr 27 07:21 PM
Hulse William Frank IV	General Counsel and CAO	Apr 25 '23	Sale	3.74	5,988	22,419	462,434	Apr 27 07:23 PM
Stein Robert Benjamin	President, Regenerative Med.	Apr 25 '23	Sale	3.74	5,987	22,415	389,400	Apr 27 07:24 PM
Phelan William Lawrence	Chief Accounting Officer	Apr 25 '23	Sale	3.74	1,628	6,095	191,014	Apr 27 07:25 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MDXG

Mimedx Group Inc

Upgrade your FINVIZ experience